UFP Technologies Inc (UFPT) News & EventsUFPTUFP Technologies Inc

UFP Technologies Reports Q2 Revenue of $174M, Beating Expectations

Reports Q2 revenue $174.0M, consensus $159.38M. The company said, "Our second quarter and first-half results reflect solid execution across the platform and continued progress toward our long-term growth strategy. In the second quarter, the team delivered 15.1% sales growth, increased gross margins to 29.3%, and grew operating income by 15.5%. These results were driven by contributions across the UFP platform, demonstrating the strength and diversity of our MedTech business. During the quarter, our top five customers grew 14.7%, the balance of our MedTech business grew 19.7%, and our non-medical business was flat. We continue to invest in our Dominican Republic operations to support customer-driven growth initiatives, expand capacity, and enhance our cost structure over time. These investments are generating early operational benefits and strengthening our ability to support future growth. While the full realization of these benefits is taking longer than anticipated, the investments are creating near-term mix and margin pressure within our U.S. operations. We also continue to strengthen our leadership team, adding experienced executives in business development, operations, and legal to increase organizational capacity and support the continued growth of the UFP platform."

Company Reports Q1 Revenue of $154.2M, Below Expectations

Reports Q1 revenue $154.2M, consensus $154.78M. "I am pleased with our first quarter results and continued progress with our strategic initiatives," said Jeffrey Bailly, Chairman and CEO. "Revenue grew 4.1%, driven by a 5.9% increase in our medical sales. This was offset by a 15% decline in our non-medical sales as we continue to focus our efforts on high-growth opportunities in the MedTech space. Our robotic surgery, patient surfaces and support, and interventional and surgical segments showed the strongest growth at 7%, 11%, and 15%, respectively. To increase capacity to meet strong forecasted demand, in Q2 we will take possession of two new facilities in the Dominican Republic - one in La Romana to support continued growth in our robotic surgery business, and one in Santiago to support growth and additional program transfers in the safe patient handling space."

Analysis of Company's 3-5 Year Financial Targets

Other 3-5 year financial targets include 28%-31% gross margin and 17%-20% operating margin. Comments taken from investor presentation slides.